-
Feb 3, 2015, 00:00 AM
by
Michael Croft
DUBAI, UNITED ARAB EMIRATES - Feb 3, 2015 - In todays brutally competitive world, what sets businesses apart is their approach and use of predictive analytics and smart data
Full story
-
Feb 2, 2015, 10:40 AM
by
Michael Croft
Bio-IT World | Semiconductor sequencing, the basis for the Ion Torrent line of whole genome sequencers, has been a bit of a flop on the market, but the technology's inventor Chris Toumazou is betting big on miniaturization at his company DNA Electronics — starting anew with point-of-care tests for infectious disease.
Full story
-
Jan 30, 2015, 06:00 AM
by
Michael Croft
Bio-IT World | President Obama will outline this morning his proposed investments to improve health and treat disease through precision medicine. The president will set out a $215m plan to build infrastructure needed to accelerate discovery in precision medicine, and includes funding for NIH and the FDA.
Full story
-
Jan 30, 2015, 00:00 AM
by
Michael Croft
New England Journal of Medicine | Francis Collins
and Harold Varmus discuss the President's Personalized Medicine
Initiative.
Full story
-
Jan 29, 2015, 10:00 AM
by
Michael Croft
Bio-IT World | BGI published the results of its non-invasive prenatal test, the NIFTY, this month in Ultrasound Obstetrics and Gynecology. The study tracked the clinical performance of the test, in nearly 147,000 pregnancies. The results showed high sensitivity and specificity and no significant difference between high-risk and low-risk pregnant women.
Full story
-
Jan 29, 2015, 00:00 AM
by
Michael Croft
PRINCETON, NJ - Jan 29, 2015 - Certara®, the global biosimulation technology-enabled drug development and drug safety consulting company, today announced that it has promoted Amin Rostami, Pharm
Full story
-
Jan 28, 2015, 11:25 AM
by
Michael Croft
Bio-IT World News Brief | The long courtroom fights are at long last coming to an end as Myriad Genetics has announced it will settle its complex web of suits and countersuits and end claims to ownership of certain genetic testing targets and methods.
Full story
-
Jan 28, 2015, 00:00 AM
by
Michael Croft
Xconomy | Cambridge, MA-based Exosome Diagnostics
aims to raise $25 million, on top of the $27 million in Series B
funding it raised last March. Exosome would use the cash to launch
its first two products: a blood-based test for lung cancer, and a
urine test for prostate cancer.
Full story
-
Jan 27, 2015, 00:00 AM
by
Michael Croft
Bloomberg | Google Inc., expanding its foray into
medical research, will join multiple sclerosis drugmaker Biogen
Idec Inc. to study environmental and biological contributors to the
debilitating disease's progression.
Full story
-
Jan 27, 2015, 00:00 AM
by
Michael Croft
- Jan 27, 2015 - Potassium
channels are attractive therapeutic targets for treatment of
cardiovascular and cancer diseases which are the top two
public-health problems for the aging population
Full story
-
Jan 27, 2015, 00:00 AM
by
Michael Croft
CHAPEL HILL, NC, UNITED STATES - Jan 27, 2015 -
WHAT: Rho, a full-service contract research
organization (CRO), will highlight its continued success in drug
development strategies and services during the Outsourcing in
Clinical Trials (OCT) West Coast conference, being held February
3-4 in Burlingame, California
Full story
-
Jan 26, 2015, 11:00 AM
by
Michael Croft
Bio-IT World News Brief | Claritas Genomics announced today that it has secured $15 million in capital for its Series B round to expand its commercial operations, launch new next generation sequencing-based tests for diagnosis of pediatric genetic disorders and continue to build its network of clinical pediatric disease experts.
Full story
-
Jan 26, 2015, 10:35 AM
by
Michael Croft
Xconomy | Yumanity, a well-connected drug discovery startup, plans to play the long game in drug development by using yeast models in deep phenotypic screens to study neurological diseases based on protein misfolding.
Full story
-
Jan 26, 2015, 08:00 AM
by
Michael Croft
Bio-IT World News Brief | Appistry today launched Appistry CloudDx Translational, a “sister product” to the CloudDx platform launched last June, now renamed CloudDx Clinical.
Full story
-
Jan 26, 2015, 00:00 AM
by
Michael Croft
DUBAI, UNITED ARAB EMIRATES - Jan 26, 2015 - Global transformation and smart data are terms bandied about in the same breath the world over. With wide-ranging implications across sectors, industries such as banking, retail and services, to name only a few, are no strangers to this trend
Full story
-
Jan 23, 2015, 00:00 AM
by
Michael Croft
- Jan 23, 2015 - IDBS has completely revitalized its ELN software for multidisciplinary research and development (R&D)
Full story
-
Jan 22, 2015, 12:20 PM
by
Michael Croft
Bio-IT World News Brief | A team based at the University of Toronto has published the first reported case of using the Oxford Nanopore MinION to sequence human DNA, in a study focused on three genes with known relevance to drug dosing.
Full story
-
Jan 22, 2015, 12:00 PM
by
Michael Croft
Bio-IT World News Brief | GenoSpace announced this morning that Michelle Munson, CEO of Aspera, an IBM Company, has joined its board as an independent director.
Full story
-
Jan 21, 2015, 13:15 PM
by
Michael Croft
Bio-IT World News Brief | Illumina today released its MiSeq FGx instrument, a version of the company's MiSeq next generation sequencer modified for forensic DNA testing, as well as ForenSeq chemistry and software kits.
Full story
-
Jan 21, 2015, 11:45 AM
by
Michael Croft
Bio-IT World | Commentators from around the science and healthcare world react to President Obama's announcement, in last night's State of the Union address, that his new budget will propose a Precision Medicine Initiative to support research into individualized therapies based on patients' unique genetic and molecular profiles.
Full story
